biote Corp
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with … Read more
biote Corp (BTMD) - Total Liabilities
Latest total liabilities as of September 2025: $176.79 Million USD
Based on the latest financial reports, biote Corp (BTMD) has total liabilities worth $176.79 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
biote Corp - Total Liabilities Trend (2019–2024)
This chart illustrates how biote Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
biote Corp Competitors by Total Liabilities
The table below lists competitors of biote Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SundayToz Corp
KQ:123420
|
Korea | ₩41.25 Billion |
|
West Point Gold Corp.
OTCQB:WPGCF
|
USA | $377.98K |
|
Western Carriers India Ltd
NSE:WCIL
|
India | ₹3.06 Billion |
|
Westport Fuel Systems Inc
NASDAQ:WPRT
|
USA | $23.87 Million |
|
Galecto Inc
NASDAQ:GLTO
|
USA | $4.07 Million |
|
Pacific West Bancorp
PINK:PWBK
|
USA | $350.38 Million |
|
Starbreeze AB (publ)
PINK:STBEF
|
USA | $120.21 Million |
|
Arcario AB
ST:ARCA
|
Sweden | Skr15.02 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down biote Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how biote Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for biote Corp (2019–2024)
The table below shows the annual total liabilities of biote Corp from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $224.57 Million | +17.06% |
| 2023-12-31 | $191.84 Million | +12.90% |
| 2022-12-31 | $169.92 Million | +238.45% |
| 2021-12-31 | $50.20 Million | +1.09% |
| 2020-12-31 | $49.66 Million | -12.60% |
| 2019-12-31 | $56.82 Million | -- |